SD

Shanghai Desano Pharmaceuticals Investment

Zhangjiang, China

About

Desino was founded in 1996 and is headquartered in Shanghai Zhangjiang Hi-Tech Park. The company's anti-AIDS drugs and anti-malarial drugs are the core development areas for the global public health crisis, and are committed to the development, production, registration and global sales of high-quality drugs.The Dyson Company R&D Center is located in Shanghai and is the National Enterprise Technology Center, the National Anti-AIDS Drug Engineering Technology Research Center and the National Postdoctoral Research Station.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 2 investors are based in Zhangjiang, Shanghai, China.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

in••••@desano.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Shanghai

Search Investors